Indeed, we found that the deletion of ACE2 causes hepatic steatosis accompanied by an impairment of the CD36/sirtuin 1 axis, insulin signaling, and glucose metabolism in the liver. The gene discussed is ACE2; the disease is Hepatic steatosis.